Teva, Watson delays yield Tetracycline shortage; Regulatory science center set at USC;

> Tetracycline tablets have found their way to the FDA drug shortages list; both Teva ($TEVA) and Watson cite manufacturing delays and neither can say when the capsules will be available. Listing

> The International Center for Regulatory Science has been established at the University of Southern California's School of Pharmacy. Release

> Applied DNA Sciences ($APDN), a company that tailors gene-splicing technology to industrial applications, is segmenting and shuffling plant DNA and adding it to printing ink as a tag that can be sensed with a handheld scanner for anticounterfeiting. Story

> Corning Life Sciences ($GLW) has opened a manufacturing and distribution facility in China's Yangtze River Delta. News

> The Shanghai Food and Drug Administration teamed with police to bust a counterfeiting ring making 66 fakes, including erectile dysfunction drugs Viagra and Xilishi. More

> Instrument supplier Analytik says the FDA has bought two LabSpec systems for counterfeit drug analysis. Article

> Aesica Pharmaceuticals, Piramal Healthcare and Shasun Pharma Solutions are among Northumberland, U.K., companies that will enjoy a $27 million government grant package intended to create or protect nearly 200 jobs. Story

> Contract manufacturer Custom Processing Services will dedicate its newly built, 42,000-square-foot manufacturing facility tomorrow at Exeter Industrial Park in Pennsylvania. News

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.